CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
92 hedge funds and large institutions have $201M invested in Concert Pharmaceuticals, Inc. in 2020 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 21 increasing their positions, 43 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
6% less capital invested
Capital invested by funds: $214M → $201M (-$13.4M)
51% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 43
Holders
92
Holding in Top 10
1
Calls
$259K
Puts
$20K
Top Buyers
| 1 | +$5.8M | |
| 2 | +$2.95M | |
| 3 | +$982K | |
| 4 |
LC
L1 Capital
Melbourne VIC 3000,
Australia
|
+$804K |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$503K |
Top Sellers
| 1 | -$3.84M | |
| 2 | -$1.54M | |
| 3 | -$1.27M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$573K |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$500K |